Recombinant CD123 (Talacotuzumab Biosimilar) antibody (Biotin)
The Humanized Monoclonal anti-CD123 (Talacotuzumab Biosimilar) antibody has been validated for ELISA, FACS and CyTox. It is suitable to detect CD123 (Talacotuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7766314
$515.90
Plus shipping costs $50.00
100 μL
Shipping to:
United States
Delivery in 6 to 8 Business Days
Quick Overview for Recombinant CD123 (Talacotuzumab Biosimilar) antibody (Biotin) (ABIN7766314)
Target
CD123 (Talacotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD123 (Talacotuzumab Biosimilar) antibody is conjugated to Biotin
Application
ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)
-
-
Purpose
- Conjugated Anti-CD123 (talacotuzuma bbiosimilar) mAb
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
-
anti-CD123 (Talacotuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Protect from light!
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C in dark for 6 months
-
-
- CD123 (Talacotuzumab Biosimilar)
-
Alternative Name
- talacotuzuma bbiosimilar
-
Target Type
- Biosimilar
-
Background
- CD123, IL3R, IL3RA
Target
-
You are here:
